Massimo Santoro

15.6k total citations · 4 hit papers
114 papers, 11.6k citations indexed

About

Massimo Santoro is a scholar working on Endocrinology, Diabetes and Metabolism, Oncology and Molecular Biology. According to data from OpenAlex, Massimo Santoro has authored 114 papers receiving a total of 11.6k indexed citations (citations by other indexed papers that have themselves been cited), including 84 papers in Endocrinology, Diabetes and Metabolism, 55 papers in Oncology and 53 papers in Molecular Biology. Recurrent topics in Massimo Santoro's work include Thyroid Cancer Diagnosis and Treatment (83 papers), Cancer-related Molecular Pathways (47 papers) and Wnt/β-catenin signaling in development and cancer (14 papers). Massimo Santoro is often cited by papers focused on Thyroid Cancer Diagnosis and Treatment (83 papers), Cancer-related Molecular Pathways (47 papers) and Wnt/β-catenin signaling in development and cancer (14 papers). Massimo Santoro collaborates with scholars based in Italy, United States and France. Massimo Santoro's co-authors include Alfredo Fusco, Francesca Carlomagno, Rosa Marina Melillo, Martin Schlumberger, Giuliana Salvatore, Rossella Elisei, James A. Fagin, Michèle Grieco, Fulvio Basolo and Samuel A. Wells and has published in prestigious journals such as Cell, Journal of Biological Chemistry and Journal of Clinical Investigation.

In The Last Decade

Massimo Santoro

112 papers receiving 11.4k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Revised American Thyroid Association Guidelines for the Management of Medullary Thyroid Carcinoma

2015 1.4k citations Samuel A. Wells, L. Sylvia et al. Thyroid profile →
Vandetanib in Patients With Locally Advanced or Metastatic Medullary Thyroid Cancer: A Randomized, Double-Blind Phase III Trial

2011 1.1k citations Samuel A. Wells, Bruce G. Robinson et al. Journal of Clinical Oncology profile →
BRAF Mutations in Thyroid Tumors Are Restricted to Papillary Carcinomas and Anaplastic or Poorly Differentiated Carcinomas Arising from Papillary Carcinomas

2003 823 citations Marina N. Nikiforova, Edna Teruko Kimura et al. The Journal of Clinical Endocrinology & Metabolism profile →
PTC is a novel rearranged form of the ret proto-oncogene and is frequently detected in vivo in human thyroid papillary carcinomas

1990 767 citations Michèle Grieco, Massimo Santoro et al. profile →

Peers

Massimo Santoro

EDM

ONCOL

GENET

PFM

Jeffrey A. Knauf United States

Kennichi Kakudo Japan

Italia Bongarzone Italy

Francesca Carlomagno Italy

Maria Luisa Carcangiu Italy

Douglas W. Ball United States

Gennaro Chiappetta Italy

Oliver Gimm Germany

Martin Schlumberger France

Hartmut P.H. Neumann Germany

Jeffrey A. Knauf United States

Massimo Santoro

6.4k ×0.8

EDM

4.2k ×1.0

3.7k ×0.9

ONCOL

1.5k ×0.8

GENET

1.3k ×0.8

PFM

Citations per year, relative to Massimo Santoro Massimo Santoro (= 1×) peers Jeffrey A. Knauf

Countries citing papers authored by Massimo Santoro

Since Specialization

Citations

This map shows the geographic impact of Massimo Santoro's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Massimo Santoro with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Massimo Santoro more than expected).

Fields of papers citing papers by Massimo Santoro

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Massimo Santoro. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Massimo Santoro. The network helps show where Massimo Santoro may publish in the future.

Co-authorship network of co-authors of Massimo Santoro

This figure shows the co-authorship network connecting the top 25 collaborators of Massimo Santoro. A scholar is included among the top collaborators of Massimo Santoro based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Massimo Santoro. Massimo Santoro is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Wells, Samuel A., L. Sylvia, Henning Dralle, et al.. (2015). Revised American Thyroid Association Guidelines for the Management of Medullary Thyroid Carcinoma. Thyroid. 25(6). 567–610. 1443 indexed citations breakdown →

Bossi, Daniela, Francesca Carlomagno, Isabella Pallavicini, et al.. (2013). Functional characterization of a novel FGFR1OP‐RET rearrangement in hematopoietic malignancies. Molecular Oncology. 8(2). 221–231. 21 indexed citations

Tamburrino, Anna, Alfredo Molinolo, Paolo Salerno, et al.. (2012). Activation of the mTOR Pathway in Primary Medullary Thyroid Carcinoma and Lymph Node Metastases. Clinical Cancer Research. 18(13). 3532–3540. 60 indexed citations

Wells, Samuel A., Bruce G. Robinson, Robert F. Gagel, et al.. (2011). Vandetanib in Patients With Locally Advanced or Metastatic Medullary Thyroid Cancer: A Randomized, Double-Blind Phase III Trial. Journal of Clinical Oncology. 30(2). 134–141. 1082 indexed citations breakdown →

Pallante, Pierlorenzo, Antonella Federico, Maria Teresa Berlingieri, et al.. (2008). Loss of the CBX7 Gene Expression Correlates with a Highly Malignant Phenotype in Thyroid Cancer. Cancer Research. 68(16). 6770–6778. 92 indexed citations

Fazioli, Francesca, Gloria Appolloni, Rina Recchioni, et al.. (2008). A New Germline Point Mutation in Ret Exon 8 (Cys ⁵¹⁵ Ser) in a Family with Medullary Thyroid Carcinoma. Thyroid. 18(7). 775–782. 21 indexed citations

Melillo, Rosa Marina, Maria Domenica Castellone, Valentina Guarino, et al.. (2005). The RET/PTC-RAS-BRAF linear signaling cascade mediates the motile and mitogenic phenotype of thyroid cancer cells. Journal of Clinical Investigation. 115(4). 1068–1081. 214 indexed citations

Salvatore, Giuliana, Gennaro Chiappetta, Yuri E. Nikiforov, et al.. (2005). Molecular profile of hyalinizing trabecular tumours of the thyroid: High prevalence of RET/PTC rearrangements and absence of B-raf and N-ras point mutations. European Journal of Cancer. 41(5). 816–821. 61 indexed citations

Nikiforova, Marina N., Edna Teruko Kimura, Manoj Gandhi, et al.. (2003). BRAF Mutations in Thyroid Tumors Are Restricted to Papillary Carcinomas and Anaplastic or Poorly Differentiated Carcinomas Arising from Papillary Carcinomas. The Journal of Clinical Endocrinology & Metabolism. 88(11). 5399–5404. 823 indexed citations breakdown →

10.

Santoro, Massimo. (2002). RET Activation and Clinicopathologic Features in Poorly Differentiated Thyroid Tumors. The Journal of Clinical Endocrinology & Metabolism. 87(1). 370–379. 26 indexed citations

11.

Collins, Barbara, Gennaro Chiappetta, Arthur B. Schneider, et al.. (2002). RET Expression in Papillary Thyroid Cancer from Patients Irradiated in Childhood for Benign Conditions. The Journal of Clinical Endocrinology & Metabolism. 87(8). 3941–3946. 48 indexed citations

12.

Chiappetta, Gennaro, Paolo Toti, Francesco Cetta, et al.. (2002). TheRET/PTCOncogene Is Frequently Activated in Oncocytic Thyroid Tumors (Hurthle Cell Adenomas and Carcinomas), but Not in Oncocytic Hyperplastic Lesions. The Journal of Clinical Endocrinology & Metabolism. 87(1). 364–369. 80 indexed citations

13.

Fusco, Alfredo, Gennaro Chiappetta, Pei Hui, et al.. (2002). Assessment of RET/PTC Oncogene Activation and Clonality in Thyroid Nodules with Incomplete Morphological Evidence of Papillary Carcinoma. American Journal Of Pathology. 160(6). 2157–2167. 110 indexed citations

14.

Creemers, Laura B., Xiaoxian Meng, Krista den Ouden, et al.. (2002). Transplantation of Germ Cells from Glial Cell Line-Derived Neurotrophic Factor-Overexpressing Mice to Host Testes Depleted of Endogenous Spermatogenesis by Fractionated Irradiation1. Biology of Reproduction. 66(6). 1579–1584. 85 indexed citations

15.

Basolo, Fulvio, Riccardo Giannini, Antonio Toniolo, et al.. (2001). Establishment of a non‐tumorigenic papillary thyroid cell line (FB‐2) carrying the RET/PTC1 rearrangement. International Journal of Cancer. 97(5). 608–614. 40 indexed citations

16.

Salvatore, Domenico, Maria Vittoria Barone, Giuliana Salvatore, et al.. (2000). Tyrosines 1015 and 1062 Arein VivoAutophosphorylation Sites in Ret and Ret-Derived Oncoproteins¹. The Journal of Clinical Endocrinology & Metabolism. 85(10). 3898–3907. 51 indexed citations

17.

Santoro, Massimo, Michèle Grieco, Rosa Marina Melillo, Alfredo Fusco, & Giancarlo Vecchio. (1995). Molecular defects in thyroid carcinomas: Role of the RET oncogene in thyroid neoplastic transformation. European Journal of Endocrinology. 133(5). 513–522. 53 indexed citations

18.

Santoro, Massimo, Rosa Marina Melillo, Michèle Grieco, et al.. (1993). The TRK and RET tyrosine kinase oncogenes cooperate with ras in the neoplastic transformation of a rat thyroid epithelial cell line.. PubMed. 4(2). 77–84. 106 indexed citations

19.

Santoro, Massimo, Yukihito Ishizaka, Toshikazu Ushijima, et al.. (1993). Involvement of RET oncogene in human tumours: specificity of RET activation to thyroid tumours. British Journal of Cancer. 68(3). 460–464. 60 indexed citations

20.

Santoro, Massimo, Francesca Carlomagno, Ian Hay, et al.. (1992). Ret oncogene activation in human thyroid neoplasms is restricted to the papillary cancer subtype.. Journal of Clinical Investigation. 89(5). 1517–1522. 307 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact